(168 days)
The demand valve is used for the application of 100 vol% oxygen during manual ventilation with the resuscitator bag, as well as during direct non-invasive inhalation with the resuscitator mask in spontaneously breathing patients.
The valve, non - rebreathing QualityFlow O2 demand valve is a medical device to deliver medical oxygen or a medical air - oxygen mixture to a patient on demand. Unlike continuous oxygen systems, the demand valve only supplies medical gas when the patient inhales, reducing oxygen consumption and ensuring the patient receives gas only when needed. The QualityFlow O2 Demand Valve from DEHAS consists of a membrane that is activated by negative pressure during inspiration and a valve mechanism that controls gas flow. During inspiration, the valve opens due to the movement of the membrane, while during expiration it is closed by a return spring. The function of the demand valve is based on providing gas only when a negative pressure is applied to the membrane, e.g. by the patient inhaling with a connected mask or suction of the resuscitator when connected (expansion after previous compression of the resuscitator). The valve therefore ensures that gas only flows when it is needed.
The provided document is a 510(k) Premarket Notification for a medical device called "QualityFlow O2 Demand Valve". This type of submission aims to demonstrate that a new device is substantially equivalent to a legally marketed predicate device, and thus does not require clinical studies in many cases.
Based on the provided text, the device in question (QualityFlow O2 Demand Valve) is a mechanical device, not an AI/software-driven one. Therefore, the questions related to AI/MRMC studies, training/test sets, ground truth establishment by experts, and adjudication methods are not applicable to this submission. The "acceptance criteria" discussed in this document refer to the device's ability to meet various engineering, safety, and performance standards, rather than diagnostic accuracy metrics common for AI/ML devices.
Here's an analysis based on the information relevant to this type of medical device submission:
1. Table of Acceptance Criteria (Relevant Standards) and Reported Device Performance:
The document summarizes non-clinical tests performed according to international standards to demonstrate substantial equivalence and that the device performs as intended.
| Acceptance Criteria (Standard Used) | Description of Test | Reported Device Performance |
|---|---|---|
| ISO 5356-1 Third edition 2004-05-15: Anaesthetic and respiratory equipment - Conical connectors: Part 1: Cones and sockets | Specifies the dimension and dimensional requirements for cones and bushings intended for the connection of anesthesia and ventilator equipment (e.g., in ventilation systems, anesthetic gas transport systems and vaporizers). | Result: pass |
| IEC 62366-1 Edition 1.1 2020-06 CONSOLIDATED VERSION: Medical devices - Part 1: Application of usability engineering to medical devices | Used to verify and validate the usability of the QualityFlow O2 demand valve. | Result: pass |
| ISO 14971 Third Edition 2019-12: Medical devices - Application of risk management to medical devices | Process for identification and assessment of hazards and associated risks, control of these risks, and monitoring effectiveness of risk control measures. | Result: pass |
| ISO 15001:2010: Anesthetic and respiratory equipment - Compatibility with oxygen | Used to ensure the oxygen compatibility of the used materials. | Result: pass |
| ISO 10993-1 Fifth edition 2018-08: Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process | Used for biological evaluation of medical devices and testing within a risk management process. | Result: pass |
| ISO 18562-1 First edition 2017-03: Biocompatibility evaluation of breathing gas pathways in healthcare applications - Part 1: Evaluation and testing within a risk management process | Evaluated biocompatibility of breathing gas pathways, specifically for indirect patient contact via medical oxygen (gas pathway contact, limited exposure < 24 hours). | Result: pass |
| ISO 18562-3: Biocompatibility evaluation of breathing gas pathways in healthcare applications - Part 3: Tests for emissions of volatile organic compounds | Assessed gas emission of VOCs with a risk assessment of any identified chemical. | Result: pass |
2. Sample Size Used for the Test Set and Data Provenance:
- Sample Size for Test Set: The document does not specify a "sample size" in terms of patient data or images, as this is a non-AI/ML mechanical device. The tests performed are laboratory/bench tests on the device itself and its components, according to the listed international standards.
- Data Provenance: Not applicable in the context of patient data. The provenance for the testing refers to the execution of tests in a laboratory setting by the manufacturer (DEHAS Medical Systems GmbH) or their designated testing facilities, adhering to international standards. The tests are non-clinical.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications:
- Not applicable. "Ground truth" in the context of device performance is established by the detailed specifications of the international standards themselves and the objective measurements derived from testing the physical device against those specifications, using calibrated equipment. There is no subjective human interpretation of patient data here that requires expert consensus for ground truth.
4. Adjudication Method for the Test Set:
- Not applicable. Adjudication methods (e.g., 2+1, 3+1) are used for resolving disagreements among human readers or expert reviewers, typically in diagnostic studies with subjective image interpretation. This is a mechanical device tested against objective engineering standards.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done:
- No. MRMC studies are specific to evaluating the diagnostic performance of AI or imaging devices with human readers interpreting cases. This device is a mechanical demand valve, not an imaging or AI diagnostic device.
6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study Was Done:
- Not applicable. This is not an algorithm. The "standalone" performance here refers to the device's inherent mechanical functionalities (e.g., flow rates, pressure triggers, material compatibility) as measured by laboratory testing according to the specified standards. All tests listed in the "Summary of non-clinical tests" (Table 3 on page 10-11) evaluate the device's technical performance.
7. The Type of Ground Truth Used:
- Ground Truth: The "ground truth" for this type of device is defined by the objective, quantifiable specifications and pass/fail criteria outlined in the referenced international standards (e.g., ISO 5356-1 for connector dimensions, ISO 15001 for oxygen compatibility, ISO 18562-3 for VOC emissions). These are engineering and safety standards, not medical diagnostic "ground truth" derived from patient outcomes or expert consensus.
8. The Sample Size for the Training Set:
- Not applicable. This is a mechanical device, not an AI/ML model that requires a training set.
9. How the Ground Truth for the Training Set Was Established:
- Not applicable. As there is no training set for an AI/ML model, no ground truth was established for it.
Summary of Study Proving Device Meets Acceptance Criteria:
The study proving the device meets the acceptance criteria is a series of non-clinical bench tests and evaluations conducted according to recognized international standards. These tests assess various aspects of the device's design, materials, usability, and performance to ensure it is safe and effective and substantially equivalent to its predicate device. The results for all listed standards were "pass", indicating the device met the pre-defined criteria for each test. The manufacturer concluded that there are "no differences which raise any different questions of safety and effectiveness" compared to the predicate device, and that its performance is "better or identical" to the predicate. No animal or clinical testing was performed for this 510(k) submission, as it was deemed unnecessary to support substantial equivalence.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. Food & Drug Administration" in blue.
October 29, 2024
DEHAS Medical Systems GmbH % Darlene Thibodeau Vice President, Ouality Assurance and Regulatory Affairs Draeger Medical Systems Inc. 6 Tech Drive Andover, Massachusetts 01810
Re: K241366
Trade/Device Name: QualityFlow O2 Series (QualityFLOW O2); QualityFlow O2 Series (OualityFLOW O2 MTV) Regulation Number: 21 CFR 868.5895 Regulation Name: Continuous Ventilator Regulatory Class: Class II Product Code: CBK Dated: May 14, 2024 Received: May 14, 2024
Dear Darlene Thibodeau:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrb/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (OS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.70) and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Re"). The UDI Rule requires, among other things, that a device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory
{2}------------------------------------------------
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Ethan L. Nyberg -S
Ethan Nyberg, Ph.D. Assistant Director DHT1C: Division of Anesthesia, Respiratory, and Sleep Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
510(k) Number (if known) K241366
Device Name
QualityFlow O2 Demand Valve (QualityFLOW O2)
Indications for Use (Describe)
The demand valve is used for the application of 100 vol% oxygen during manual ventilation with the resuscitator bag, as well as during direct non-invasive inhalation with the resuscitator mask in spontaneously breathing patients. CAUTION:
Federal law restricts this device to sale by or on the order of a physician
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{4}------------------------------------------------
8 510(K) SUMMARY
In accordance with 21 CFR 807.92 the following summary of information is provided:
Date: October 25, 2024
Type: Traditional 510(k)
8.1 Submitter DEHAS Medical Systems GmbH Wesloer Straße 107-109 23568 Luebeck, Germany
Primary contact person
Jens Mittendorf Managing Director Phone: +49-451-80904-200 +49-451-80904-111 Fax: E-Mail: J.Mittendorf@dehas.de
8.2 Device Name
Proprietary / device trade name: QualityFlow O2 Demand Valve Common name: Valve, Non-rebreathing Classification name: 868.5870 Non-rebreathing Valve Models: D-DV-W QualityFlow O2 Demand Valve
{5}------------------------------------------------
8.3 Predicated device equivalence
DEHAS Medical Systems GmbH is claiming substantial equivalence to the SPIRA-CLE TECHNOLOGY GASEOUS OXYGEN SUPPLY VALVE (K953349) from Spiracle Technology, 10601 Calle Lee # 190, Los Alamitos, CA 90720.
8.4 Indications for Use (IFU)
The demand valve is used for the application of 100 vol% oxygen during manual ventilation with the resuscitator bag, as well as during direct non-invasive ventilation with the resuscitator mask in spontaneously breathing patients.
CAUTION:
Federal law restricts this device to sale by or on the order of a physician
Comparison of Indications for use (IFU)
| Old | New |
|---|---|
| The demand valve is used for theapplication of 100 vol% oxygen duringmanual ventilation with the resuscitatorbag, as well as during direct non-invasiveinhalation with the resuscitator mask inspontaneously breathing patients.WARNING:This device is not a resuscitator. ThisDevice is not suitable for invasive use onthe tube. This device should be usedsolely as an assessor with a bag valveresuscitator or a mask via compatibleadapters.CAUTION:Federal law restricts this device to sale byor on the order of a physician | The demand valve is used for theapplication of 100 vol% oxygen duringmanual ventilation with the resuscitatorbag, as well as during direct non-invasive ventilation with the resuscitatormask in spontaneously breathingpatients.CAUTION:Federal law restricts this device to sale byor on the order of a physician |
Response to Changes in the Indications for Use (IFU) Statement
In response to FDA requirements, we have revised the Indications for Use (IFU) statement for the demand valve to ensure clarity and consistency with the predicate device (Spiracle Technology OX - series, HFOC High Flow Oxygen Conserver Model No. 301, K953349). The changes focus on refining the intended use and removing unnecessary limitations to support better understanding and safe use of the device.
Removal of Restrictive Warnings
- Rationale: The original IFU included warnings such as "This device is not a o resuscitator," "This device is not suitable for invasive use on the tube," and "This device should be used solely as an assessor...." These statements have been removed to avoid potential misunderstandings, as the demand valve is designed to provide manual ventilation with a resuscitator bag and non-invasive ventilation for spontaneously breathing patients, similar to the predicate device. By removing these warnings, the IFU now accurately reflects the actual intended use of the device without introducing unnecessary restrictions to its capabilities.
Clarification of Indications for Use (IFU)
- The revised IFU now clearly specifies that the demand valve is intended for the o application of 100% oxygen during manual ventilation with the resuscitator bag,
{6}------------------------------------------------
as well as non-invasive ventilation with the resuscitator mask for spontaneously breathing patients. This refined description establishes a clear distinction from invasive ventilation, ensuring that the device's intended use is accurately and consistently described according to FDA requirements and the predicate device.
Retention of Legal Caution Statement
- The legally required statement that restricts the sale of the device to those with o a physician's order ("Federal law restricts this device to sale by or on the order of a physician") remains unchanged to comply with legal requirements and ensure safe use.
Summary These changes ensure that the IFU accurately and clearly defines the demand valve's intended use by removing unnecessary limitations and aligning with FDA requirements and the predicate device.
8.5 Patient Group
The Valve. Non-rebreathing QualityFlow O2 demand valve may be used on equipment where patient population is children and adults.
8.6 Environments of use
Emergency care, Emergency medical Service (EMS), hospital and anaesthesie settings.
8.7 User group
Emergency care professionals, hospital respiratory care practitioners, anesthesiologists
Device description 8.8
The valve, non - rebreathing QualityFlow O2 demand valve is a medical device to deliver medical oxygen or a medical air - oxygen mixture to a patient on demand. Unlike continuous oxygen systems, the demand valve only supplies medical gas when the patient inhales, reducing oxygen consumption and ensuring the patient receives gas only when needed.
The demand valve is intended for the following methods of respiratory support:
Method: Demand Valve with Resuscitation Bag:
Function of the Demand Valve: When combined with a resuscitation bag, the demand valve controls the flow of oxygen when the patient is breathing spontaneously. The valve only releases oxygen or air when the patient inhales. The resuscitation bag, can be used to provide manual ventilation in case the patient is unable to breathe on their own.
Application: If the patient is breathing spontaneously, the resuscitation bag remains in standby and can be manually compressed to provide emergency ventilation. Meanwhile, the demand valve automatically supplies oxygen as needed without requiring manual intervention while the patient breathes independently.
Method: Demand Valve with Resuscitation Bag:
Function of the Demand Valve: The mask is placed over the patient's face and connected to the demand valve. The valve delivers oxygen through the mask when the patient inhales and closes during exhalation to prevent gas loss.
Application: This configuration is ideal for patients who are breathing on their own but require supplemental oxygen. The mask ensures a tight seal around the airways, allowing the demand valve to function efficiently. The patient receives only the required amount of gas, minimizing wastage and ensuring higher efficiency.
{7}------------------------------------------------
Three adapter are available for connecting the demand valve to the most common ventilation bags or masks.
Method: Demand Valve and Air - Oxygen Blender:
Function of the Demand Valve: The air-oxygen blender mixes ambient air with oxy-gen to create a specific oxygen concentration (FiO2). This mixture is then delivered to the demand valve, which provides the blended gas to the patient only during inhalation.
Application: The blender ensures that the patient receives an exact oxygen concentration, which is delivered via the demand valve. The demand valve releases the gas only during the patient's inhalation, improving efficiency and reducing gas consumption. This setup is particularly useful in clinical situations where precise oxygen delivery is required.
| Version | Description | Picture |
|---|---|---|
| D-DV-W | QualityFlow O2 DemandValve | Image: QualityFlow O2 Demand Valve |
The QualityFlow O2 demand valve is provided in the following model:
Table 1: Models QualityFlow O2 demand valve
8.9 Technology
The Valve, Non-rebreathing QualityFlow O2 Demand Valve (also known as a non-rebreathing valve) is a specialized airway device used in patients who have difficulty breathing adequately or who require controlled breathing. It is a device that delivers a controlled amount of medical oxygen to the patient based on the patient's breathing needs. The QualityFlow O2 Demand Valve from DEHAS consists of a membrane that is activated by negative pressure during inspiration and a valve mechanism that controls gas flow. During inspiration, the valve opens due to the movement of the membrane, while during expiration it is closed by a return spring.
The function of the demand valve is based on providing gas only when a negative pressure is applied to the membrane, e.g. by the patient inhaling with a connected mask or suction of the resuscitator when connected (expansion after previous compression of the resuscitator). The valve therefore ensures that gas only flows when it is needed.
The demand valve can be in 3 states:
Resting state: When the patient does not inhale, the valve is closed. The return spring holds the diaphragm in a position that closes the exhaust valve.
Inhalation: When the patient inhales, a negative pressure is created. This negative pressure tightens the membrane, which opens the outlet valve and allows gas to flow through.
Exhalation: When exhaling, the pressure acting on the membrane becomes positive, causing the return spring to push the membrane back to its original position and close the exhaust valve. This prevents the gas from flowing further.
The flow of the Valve, Non-rebreathing QualityFlow O2 is pressure controlled.
{8}------------------------------------------------
8.10 Determination of substantial equivalence
The subject device has the same indication for use, the same patient group, and the same environment of use as the predicate device SPIRACLE TECHNOLOGY GASE-OUS OXYGEN SUPPLY VALVE (K953349).
The subject device also has the same technological characteristics for example design components, the same function and uses the same energy source as the predicate device SPIRACLE TECHNOLOGY GASEOUS OXYGEN SUPPLY VALVE (K953349).
| Please see the table below for more details. | |
|---|---|
| ---------------------------------------------- | -- |
| Item / Manufacturer | QualityFlow O2 demandvalveDEHAS Medical SystemsGmbHWesloer Str. 107-10923568 Luebeck, Germany | SPIRACLE TECHNOLOGYGASEOUS OXYGEN SUP-PLY VALVESpiracle TechnologyA FERNO Group Company10601 Calle Lee #190Los Alamitos, CA 90720 |
|---|---|---|
| Product family | QualityFlow O2 DemandValve | Spiracle Technology OX –series |
| Model | D-DV-W | HFOC High Flow OxygenConserverModel No. 301 |
| 510 (K) Number | K241366 | (K953349) |
| Product Code | CBP | CBP |
| Regulation Number | 21 CFR 868.5870 | 21 CFR 868.5870 |
| Patient Group | Adults and children | Children and Adults |
| Environments of use | Emergency care, hospitalenvironment | Emergency care, hospital |
| User Group | Emergency care profession-als, hospital respiratory carepractitioners, anesthesiolo-gists | Emergency care profession-als, hospital respiratory carepractitioners, anesthesiolo-gists |
| Gas source | 100 % medical oxygen | 100 % medical oxygen |
| Pressure Trigger | - 0,5 to -1,2 cm H2O | 0 to 0,5 cm H2O (standard) |
| Maximum Flow | Nominal ≥160 liters per mi-nute | Nominal 160 liters per minute |
| Pressure relief | Ambient pressure conditions | Ambient pressure conditions |
| Demand mode | Yes | Yes |
| Oxygen inlet gas pres-sure | 2,8 bar - 5,5 bar(40,61 - 79,8 psig) | 2,7 bar - 6,2 bar(40 - 90 psig) |
| Operating temperature | -20°C up to +70°C (-4° F upto +158°F) | -30° to 125°F (-34° to 52°C) |
| Storage temperature | -20°C up to +40°C (-4°F upto +104° F) | -40° to 160°F (-40° to 71°C) |
| Dimensions | 4,9 cm diameter x 56 mm(width incl. inlet) x 79 mm(height) | 4,74 cm diameter x 57,9 mm(width incl. inlet) x 70,8 mm(height) |
| Item / Manufacturer | QualityFlow O2 demand valveDEHAS Medical Systems GmbHWesloer Str. 107-10923568 Luebeck, Germany | SPIRACLE TECHNOLOGY GASEOUS OXYGEN SUP-PLY VALVESpiracle TechnologyA FERNO Group Company10601 Calle Lee #190Los Alamitos, CA 90720 |
| Weight | 153 gram | 270 gram |
| Inlet fitting | Standard inlet fitting male ox-ygen diss | Standard inlet fitting male ox-ygen diss |
| Outlet fitting | Thread for connecting a con-ical adapter according to ISO5356-1 Third edition 2004-05-15Anaesthetic and respiratoryequipment - Conical con-nectors: Part 1: Cones andsockets | Thread for connecting a coni-cal adapter according to ISO5356-1 Third edition 2004-05-15Anaesthetic and respiratoryequipment - Conical connect-ors: Part 1: Cones and sock-ets |
| Available accessories | ||
| Medical oxygen hose | According to ISO 5359Fourth edition 2014-10-01Anaesthetic and respiratoryequipment - Low-pressurehose assemblies for use withmedical gases [IncludingAMENDMENT 1 (2017)] | According to ISO 5359Fourth edition 2014-10-01Anaesthetic and respiratoryequipment - Low-pressurehose assemblies for use withmedical gases [IncludingAMENDMENT 1 (2017)] |
| Adapter | according to ISO 5356-1Third edition 2004-05-15Anaesthetic and respiratoryequipment - Conical con-nectors: Part 1: Cones | according to ISO 5356-1Third edition 2004-05-15Anaesthetic and respiratoryequipment - Conical connect-ors: Part 1: Cones |
| Adapter Size | QualityFlow O2 DemandValve Adapter:P/N: D - 252200226/31 mm I.D. / O.D. adapterP/N: D – DAN-25220015/22 mm I.D. / O.D. adapterP/N: D - 2522001 | HFOC Resuscitator Adapter:P/N: 252200226/31 mm I.D. / O.D. adapterP/N: 252200315/22 mm I.D./O.D. internalribbed adapterP/N: 2522004 |
{9}------------------------------------------------
Table 2: Table of comparison
The following quality assurance measures were applied to the development of the device:
- . Risk analysis
- . Requirements evaluation reports
- Raw materials verification ●
- Final acceptance testing requirements .
- Performance testing verification .
{10}------------------------------------------------
8.11 Summary of non - clinical tests
For comparison, we performed a number of non-clinical tests according to the equivalent standards to demonstrate that the subject device performs as intended and is substantial equivalent to the predicate device SPIRACLE TECHNOLOGY GASEOUS OX-YGEN SUPPLY VALVE (K953349).
We used the following international standards for testing to demonstrate substantial equivalence:
| Used Standard | Standard used for | Result: |
|---|---|---|
| Pass /fail | ||
| ISO 5356-1 Third edi-tion 2004-05-15Anaesthetic and respir-atory equipment - Coni-cal connectors: Part 1:Cones and socketsFR Recognition ListNumber: 028FR Recognition Num-ber: 1-62 | This ISO 5356-1:2004 stand-ard was used to specify the di-mension and dimensional re-quirements specified in thestandard for cones and bush-ings intended for the connec-tion of anesthesia and ventila-tor equipment, e.g. B. in venti-lation systems, anesthetic gastransport systems and vapor-izers. | Result: pass |
| IEC 62366-1 Edition1.1 2020-06 CONSOLI-DATED VERSIONMedical devices - Part1: Application of usabil-ity engineering to medi-cal devicesFR Recognition ListNumber: 054FR Recognition Num-ber: 5-129 | This standard has been usedto verify and validate the usa-bility of the QualityFlow O2demand valve | Result: pass |
| ISO 14971 Third Edi-tion 2019-12Medical devices - Appli-cation of risk manage-ment to medical de-vicesFR Recognition ListNumber: 053FR Recognition Num- | This international standardhas been used as a processfor our medical devices forthe identification and assess-ment of hazards and associ-ated risks, the control ofthese risks and the monitor-ing of the effectiveness of riskcontrol measures. | Result: pass |
| ber: 5-125ISO 15001:2010 Anes-thetic and respiratoryequipment - Compati-bility with oxygen | The standard has been usedto ensure the oxygen com-patibility of the used materi-als. | Result: pass |
| ISO 10993-1 Fifth edi-tion 2018-08Biological evaluation ofmedical devices - Part1: Evaluation and test-ing within a risk man-agement processFR Recognition ListNumber: 051FR Recognition Num-ber: 2-258 | The standard has been usedfor biological evaluation ofmedical devices and testingwithin a risk managementprocess | Result: pass |
| ISO 18562-1 First edi-tion 2017-03Biocompatibility evalua-tion of breathing gaspathways in healthcareapplications - Part 1:Evaluation and testingwithin a risk manage-ment processFR Recognition ListNumber: 049FR Recognition Num-ber: 1-134 | The standard has been usedfor Biocompatibility evalua-tion of breathing gas path-ways in healthcare applica-tions.Contact classification of theQualityFlow O2 demandvalve:Indirect patient contact pro-vided via medical oxygensupplied to the patient (gaspathway contact), for medicaldevices with gas pathwaycontact to the patient, compli-ance to ISO 18562-1 is re-quiredDuration:limited exposure - MEDICALDEVICE, part or ACCES-SORY whose cumulative sin-gle, multiple or repeated usedoes not exceed 24 hourswithin the scope of the stand-ard ISO 18562-1 | Result: pass |
| ISO 18562-3Biocompatibility evalua-tion of breathing gaspathways in healthcareapplications - Part 3:Tests for emissions ofvolatile organic com-poundsFR Recognition ListNumber: 049FR Recognition Num-ber: 1-134 | Biocompatibility evaluation ofbreathing gas pathways inhealthcare applications.Gas emission VOC assess-ment with a risk assessmentof any identified chemical. | Result: pass |
{11}------------------------------------------------
Table 3: Summary of non - clinical tests
{12}------------------------------------------------
Conclusion:
In all cases the subject device passed or meets the acceptance criteria of general requirements for performance and basic safety. We can find the subject device substantially equivalent to the predicate device SPIRACLE TECHNOLOGY GASEOUS OXY-GEN SUPPLY VALVE (K953349).
There are no differences which raise any different questions of safety and effectiveness.
8.12 Animal testing
No animal testing was performed.
8.13 Clinical tests
The subject of this premarket submission, QualityFlow O2 demand valve, do not require clinical studies to support substantial equivalence.
8.14 Discussion of Differences
There are a few differences between the subject device and the predicate device SPIR-ACLE TECHNOLOGY GASEOUS OXYGEN SUPPLY VALVE (K953349). The differences between the predicate and the subject device are addressed when we compare the subject device to the reference devices. The differences are outlined and discussed in the Substantial equivalence discussion.
8.15 Substantial equivalence conclusion
As outlined in the equivalence discussion, differences of the devices do not raise any questions of effectiveness and safety. Evaluation and performance tests according to the used equivalent standards show, that the subject device passed and meets the acceptance criteria and the performance is better or identical than the predicate device. We can find the subject device substantially equivalent to the predicate device SPIR-ACLE TECHNOLOGY GASEOUS OXYGEN SUPPLY VALVE (K953349).
DEHAS Medical Systems GmbH considers the QualityFlow O2 demand valve to be as safe, as effective, and performance is substantially equivalent to the predicate device SPIRACLE TECHNOLOGY GASEOUS OXYGEN SUPPLY VALVE (K953349).
Submitted by:
Jens Mittendorf Manaqing Director DEHAS Medical Systems GmbH
§ 868.5870 Nonrebreathing valve.
(a)
Identification. A nonrebreathing valve is a one-way valve that directs breathing gas flow to the patient and vents exhaled gases into the atmosphere.(b)
Classification. Class II (performance standards).